{
    "2020-09-17": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Abbott Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Gains",
                        "Market",
                        "Dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Abbott Declares 387th Consecutive Quarterly Dividend",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Dividend",
                        "Consecutive",
                        "Quarterly"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Abbott Introduces Libre Sense Glucose Sport Biosensor in Europe, World's First Glucose Biosensor Designed for Athletes",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Libre",
                        "Sense",
                        "Glucose",
                        "Biosensor",
                        "Athletes"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "RPT-FOCUS-U.S. plans for hundreds of millions of cheap, fast COVID-19 tests",
                "features": {
                    "keywords": [
                        "U.S.",
                        "plans",
                        "COVID-19",
                        "tests",
                        "cheap",
                        "fast"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}